IRIS
NOBILI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 988
EU - Europa 764
AS - Asia 719
SA - Sud America 123
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 969
SG - Singapore 635
IE - Irlanda 323
SE - Svezia 193
IT - Italia 121
BR - Brasile 112
DE - Germania 35
HK - Hong Kong 28
RU - Federazione Russa 25
AT - Austria 13
CA - Canada 13
GB - Regno Unito 12
VN - Vietnam 12
CN - Cina 10
IN - India 9
UA - Ucraina 7
FI - Finlandia 6
BD - Bangladesh 5
BE - Belgio 5
LT - Lituania 5
PL - Polonia 5
CZ - Repubblica Ceca 4
RO - Romania 4
TR - Turchia 4
AR - Argentina 3
EU - Europa 3
MX - Messico 3
UZ - Uzbekistan 3
AL - Albania 2
ID - Indonesia 2
IQ - Iraq 2
MA - Marocco 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FR - Francia 1
GI - Gibilterra 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
ZA - Sudafrica 1
Totale 2.604
Salva come PNG Salva come JPEG
Città #
Singapore 489
Dublin 323
Princeton 172
Santa Clara 112
Altamura 90
Jacksonville 79
Wilmington 56
Hong Kong 28
Chandler 22
The Dalles 17
Norwalk 15
Nuremberg 14
Dong Ket 12
Chicago 9
London 8
Munich 8
São Paulo 7
Ashburn 5
Brussels 5
Curitiba 5
Milan 5
Montreal 5
New York 5
Rio de Janeiro 5
San Francisco 5
Brno 4
Hangzhou 4
Helsinki 4
Los Angeles 4
Porto Alegre 4
Romola 4
Toronto 4
Vienna 4
Frankfurt am Main 3
Nanjing 3
Recife 3
Secaucus 3
Tashkent 3
Andover 2
Aparecida de Goiânia 2
Boston 2
Brooklyn 2
Cabo Frio 2
Chieti 2
Fairfield 2
Florence 2
Istanbul 2
Lappeenranta 2
Lorena 2
Manchester 2
Massarosa 2
Montevideo 2
Ottawa 2
Phuket 2
Tirana 2
Aberdare 1
Agadir 1
Algiers 1
Altamira 1
Amman 1
Antalya 1
Arapoti 1
Araraquara 1
Araras 1
Araxá 1
Arcos 1
Asunción 1
Auckland 1
Bambuí 1
Barra do Piraí 1
Barrackpore 1
Belford Roxo 1
Berazategui 1
Bertioga 1
Bishkek 1
Boa Esperança 1
Boardman 1
Bonn 1
Botucatu 1
Brasília 1
Bridgetown 1
Bursa 1
Cachoeiras de Macacu 1
Cachoeirinha 1
Cairo 1
Cajamar 1
Calgary 1
Camerino 1
Campinas 1
Campo Grande 1
Capâo Bonito 1
Caracas 1
Caraguatatuba 1
Caruaru 1
Catanduvas 1
Celaya 1
Cesário Lange 1
Chavantes 1
Chennai 1
Cleveland 1
Totale 1.627
Salva come PNG Salva come JPEG
Nome #
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 56
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 54
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents 54
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia 51
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 50
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 46
Cellular pharmacology of gemcitabine 46
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study 46
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 45
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 45
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 43
Efficacy evaluation of plant products in the treatment of erectile dysfunction related to diabetes 43
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action 42
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight 42
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds 42
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study 42
Prognostic factors in primary and iterative surgery of colorectal liver metastases 42
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience 40
Genomic and genetic alterations infuence the progression of gastric cancer 40
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 39
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer 39
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients 39
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer 38
Chronic inflammation in urothelial bladder cancer 38
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 38
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 37
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions 37
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipyc 37
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma 37
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer 37
Druggable targets in pancreatic adenocarcinoma 36
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 36
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 36
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy 35
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues 35
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand 35
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment 34
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 34
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 33
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 33
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 33
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 33
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 32
Emerging drugs in refractory colorectal cancer 32
Gold compounds as anticancer agents: Chemistry, cellular pharmacology, and preclinical studies 32
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules 32
Role of ATP-binding cassette transporters in cancer initiation and progression 31
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 31
Establishment and characterization of a new spontaneously immortalized ER -/PR -/HER2 + human breast cancer cell line, DHSF-BR16 31
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 31
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer 31
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 30
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains 30
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study 30
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways 30
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 30
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2′-pyridyl)benzimidazole as ligand: Comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 30
Pharmacogenetics: Implementing personalized medicine 30
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 29
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 29
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 29
Natural compounds for cancer treatment and prevention 29
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors 28
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 28
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 28
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study 28
Pharmacological strategies for overcoming multidrug resistance 28
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 27
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 27
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer 27
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer 27
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? 27
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 26
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience 25
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 25
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 25
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 25
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature 25
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 24
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? 24
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery 23
Size dependent biological profiles of PEGylated gold nanorods 23
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials 22
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 22
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 22
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 22
Maintenance in gastric cancer: New life for an old issue? 19
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 18
Totale 2.952
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021454 0 0 0 0 138 227 13 8 14 13 14 27
2021/2022214 1 4 3 2 4 0 2 21 28 6 50 93
2022/2023568 98 98 79 1 3 147 68 21 44 6 3 0
2023/2024304 12 27 20 18 12 82 98 0 0 5 8 22
2024/20251.412 103 464 295 11 37 8 43 39 163 65 96 88
Totale 2.952